Table 2. Overall survivals of each of the four MMR/BRAF phenotypes by Kaplan Meier actuarial analysis.
MMR/BRAF phenotype | 5-year survival | Mean survival |
MMRp/BRAFV600E | 52.6% | 7.12 years (95%CI = 5.87–8.37) |
MMRd/BRAFwt | 64.2% | 8.36 years (95%CI = 6.16–10.56) |
MMRd/BRAFV600E | 64.1% | 8.08 years (96%CI = 7.04–9.40) |
MMRp/BRAFwt | 60.1% | 8.06 years (95%CI = 7.62–8.50) |